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Abstract
Background: In the United States, the risk of rabies transmission to humans in most situations of possible exposure is 
unknown. Controlled studies on rabies are clearly not possible. Thus, the limited data on risk has led to the frequent 
administration of rabies post-exposure prophylaxis (PEP), often in inappropriate circumstances.
Methods: We used the Delphi method to obtain an expert group consensus estimate of the risk of rabies transmission 
to humans in seven scenarios of potential rabies exposure. We also surveyed and discussed the merits of 
recommending rabies PEP for each scenario.
Results: The median risk of rabies transmission without rabies PEP for a bite exposure by a skunk, bat, cat, and dog was 
estimated to be 0.05, 0.001, 0.001, and 0.00001, respectively. Rabies PEP was unanimously recommended in these 
scenarios. However, rabies PEP was overwhelmingly not recommended for non-bite exposures (e.g. dog licking hand 
but unavailable for subsequent testing), estimated to have less than 1 in 1,000,000 (0.000001) risk of transmission.
Conclusions: Our results suggest that there are many common situations in which the risk of rabies transmission is so 
low that rabies PEP should not be recommended. These risk estimates also provide a key parameter for cost-effective 
models of human rabies prevention and can be used to educate health professionals about situation-specific 
administration of rabies PEP.
Background
Approximately 6,000 to 7,000 cases of animal rabies are
reported each year to the CDC, while there were 19
human cases indigenously acquired over the period 2000
- 2006 [1]. Annually, 16,000-39,000 people in the United
States are potentially exposed to rabies and receive post-
exposure prophylaxis (PEP), and none has ever developed
rabies [2]. However, it is unclear whether the rarity of
human rabies in the United States is due to low risk of
acquisition, the effectiveness of rabies PEP, or both [3].
The number of rabid domestic animals (the most com-
mon vector of human rabies in the 20th century in the
United States as well as most other parts of the world) has
also decreased. The number of PEP courses -- the direct
cost of which is approximately $2,500 per fully treated
patient -- has increased without any decrease in the num-
ber of human rabies cases [2,4,5]. Thus, PEP is often
administered under inappropriate circumstances [6,7].
Health practitioners lack information allowing them to
estimate the risk of rabies, complicating decisions on how
t o  p r o c e e d  w h e n  d e a l i n g  w i t h  v a r i o u s  l o w - r i s k  r a b i e s
encounters, such as non-bites [8].
Currently, little information exists on the risk of rabies
transmission in situations in which the risk is low, and
controlled studies in humans are neither feasible nor eth-
ical. Therefore, we used the Delphi technique to estimate
(1) the risk of rabies transmission to humans and (2) the
circumstances following which rabies PEP should not be
recommended in various potential exposure scenarios
common in the United States.
Methods
This study was classified as exempt from human subject
regulations by the Institutional Review Board of the Cen-
ters for Disease Control and Prevention. Recent studies
have shown the utility of using the Delphi technique to
obtain information about vaccines in situations where
clinical trials are not feasible [9]. W e developed a two-
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part protocol to estimate (1) the risk of rabies transmis-
sion to humans and (2) the circumstances following
which rabies PEP should/should not be recommended.
We used the Delphi technique to obtain a group consen-
sus estimate of the risk of human rabies infection and the
treatment practices using various potential exposure sce-
narios common in the United States [10]. The group was
made up of public health professionals with experience in
making decisions regarding administration of human
rabies PEP on a regular occupational basis. A list of the
panel members is provided in the Acknowledgment sec-
tion.
Potential participants received an introductory ques-
tionnaire by email that requested information regarding
the duration and type of experience they have had in rec-
ommending rabies PEP. The email clearly indicated that
participation in the study was purely voluntary. After
selection of the study panel, the study coordinator
(S.A.V.) distributed a questionnaire consisting of seven
scenarios of potential rabies exposures to different spe-
cies (see Table 1, Appendix 1). In six of the scenarios, the
animal responsible was not available for rabies testing.
Three of the exposures were unprovoked bites and three
were unprovoked licks by animals. The seventh was a
possible exposure to a human rabies patient. Each sce-
nario provided an estimate of the prevalence of rabies in
the involved animal species based on information from
published literature as follows: skunk 25%, bat 15%, cat
1%, and dog 0.1% [3,11,12]. Participants were also pro-
vided reference values of actual rabies mortality following
different exposures to proven rabid animals based on the
following published values: superficial bite to the hand:
5%; contact with rabid saliva on a recent wound: 0.1%;
contact with rabid saliva on a wound older than 24 hours:
0.0% [13]. Finally, all scenarios standardized the post-
exposure course with "the wound is not washed or
cleaned" and "the animal cannot be found" in order to
maintain clarity and consistency across potential expo-
sure scenarios.
In each round of the Delphi survey, responses from the
participants were recorded anonymously under a pseud-
onym. For subsequent rounds, each participant received
the aggregate results of the previous round and was asked
to complete the questionnaire again taking into account
the results from the previous round. The participants
were also encouraged to provide comments regarding
why they agreed or disagreed with the aggregated results
and to explain the thought process behind their esti-
mates. Relevant comments were anonymously included
in subsequent rounds, with the anonymity of all
responses preserved by editing explanations so that the
respondent could not be identified. The questionnaire
was completed by all the participants in three sequential
rounds, by which time the results had stabilized and
respondents were firm in their responses. The estimates
f o r  t h e  r i s k  o f  r a b i e s  t r a n s m i s s i o n  a n d  t h e  n u m b e r  o f
respondents recommending rabies PEP were calculated
for each scenario and for all scenarios combined.
Results
We contacted 27 public health professionals with signifi-
cant experience in the fields of rabies and PEP. Twenty
Table 1: Scenarios presented in the Delphi Questionnaire¶..
Scenario Animal Contact scenario Prevalence*
1 Skunk Bite 25%
2 Bat Unknown** 15%
3 Dog Bite 0.1%
4 Dog Lick 0.1%
5C a t B i t e 1 %
6C a t L i c k 1 %
7 Human Unknown*** 100%****
¶ See Appendix for complete questionnaire containing full descriptions of each scenario.
* Estimated prevalence rate consistent with published rates of animal rabies
** No obvious bites or skin abrasions, however bat bites are often not visible and patient history was unreliable (infant)
*** No bites, scratches, or direct contact with patient's saliva, however close contact for ten days (nursing)
**** The human exposure was a confirmed rabies caseVaidya et al. BMC Public Health 2010, 10:278
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participants completed the study, four did not reply to the
initial survey, two declined due to insufficient time, and
one was unable to complete the final round due to medi-
cal illness. All participants had experience in assessing
risk of rabies transmission and in recommending rabies
PEP ranging from 2 years to over 30 years (median = 13)
and 75 to >6000 individual rabies consultations (median
= 1700). Most (75%) participants were affiliated with state
public health departments while 25% were affiliated with
national public health departments.
A summary of the panel's estimates for risk of rabies
can be found in Table 2. The panel rated the first sce-
nario, which described a bite from a skunk in an area in
which 25% of tested skunks were positive for rabies, as
representing the greatest risk of human rabies infection.
Only 4 participants provided estimates different than the
median value of 0.05. All participants indicated that they
would recommend rabies PEP in such a scenario.
The panel judged that the second and fifth scenarios,
which described a potential bat bite and superficial cat
bite, respectively, to represent the next highest risk of
rabies transmission, with a median risk of 0.001. How-
ever, these scenarios had wide variations. For example,
for the bat scenario, estimates of the risk of transmission
ranged from 0.01 to 0.000001, and the risk of transmis-
sion following a cat bite had an even wider range (Table
2). In both scenarios, all participants recommended PEP.
The third scenario, which described a superficial dog bite,
was graded as having a lower risk with a median value of
0.00001 (range: 0.001 to 0.00001). However, only one par-
ticipant asserted that PEP was not necessary and the
remainder noted that they would recommend rabies PEP.
Comparison of the respondents' risk estimates versus
their PEP recommendations are presented graphically in
Figure 1.
For scenarios 4, 6, and 7, which describe a dog lick, a cat
lick, and contact with a human rabies patient, respec-
tively, over 90% of the participants estimated the risk to
be <0.000001 (i.e. 1 in 1,000,000 or less). For these scenar-
ios, panelists had differences during the initial rounds of
the survey regarding rabies PEP recommendations. These
differences resolved over subsequent rounds of the sur-
vey and over 90% of participants eventually did not rec-
ommend rabies PEP for scenarios 4 and 6. For scenario 7,
20% (4 of 20) participants recommended PEP, one partic-
ipant was unsure, and the remainder recommended
against administering rabies PEP.
Table 2: Estimates of the Risk of Rabies Transmissiona.
Scenario Exposure b 25th 
percentile
50th 
percentile
75th 
percentile
Range Recommend 
PEP (% "yes")c
1 Skunk (bite) 0.05 0.05 0.05 0.1 - 0.01 100
2 Bat (unk) 0.0001 0.001 0.001 0.01 - 
0.000001
100
3 Dog (bite) 0.00001 0.00001 0.0001 0.001 - 
0.00001
95
4 Dog (lick) 0.000001 0.000001 0.000001 0.00001 - 
0.000001
10
5 Cat (bite) 0.0001 0.001 0.001 0.01 - 0.00001 100
6 Cat (lick) 0.000001 0.000001 0.000001 0.0001 - 
0.000001
5
7 Human (unk) 0.000001 0.000001 0.000001 0.00001 -
0.000001
20
a Study participants were asked to estimate the probability of developing rabies without rabies post-exposure prophylaxis for each indicated 
potential exposure scenario
b bite - superficial laceration, area not washed or cleaned; lick - over skin with recent superficial scratches, area not washed or cleaned; unk - 
unknown if true exposure, no obvious bites, scratches, or direct contact with bodily fluids
c Percentage of panel members recommending rabies post-exposure prophylaxis (PEP) for the indicated scenarioVaidya et al. BMC Public Health 2010, 10:278
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Figure 1 Comparison of the estimated risk of rabies and PEP recommendations. Respondents' estimates of the risk of transmission of human 
rabies without post-exposure prophylaxis (PEP) (shown in yellow) and the number recommending PEP (shown in red) in different potential exposure 
scenarios.
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Discussion
Our panel estimated that the median risk of rabies trans-
mission after bite exposure by a skunk, bat, cat, and dog
was estimated to be 0.05, 0.001, 0.001, and 0.00001,
respectively. All participants recommended rabies PEP in
these scenarios. The median estimated risk after possible
non-bite exposure to a dog, a cat, or human with rabies
was less than 0.000001 and rabies PEP was usually not
recommended. The estimates obtained in this analysis
provide a key parameter for the economic analysis of
public health measures for rabies prevention. In addition,
these results provide information that may be useful in
clinical decisions regarding the administration of rabies
PEP in potential exposure scenarios.
Cases of human rabies are almost inevitably fatal. Thus,
the decision to recommend for or against rabies PEP can
be a life or death decision. When making a decision
whether or not to recommend rabies PEP, the person
making the recommendation must take into consider-
ation widely differing risks based on the severity of expo-
sure and the prevalence of rabies in the exposing animal
species. Complicating the evaluation of the risks and ben-
efits of administering rabies PEP is the fact that limited
information may be available at the time a treatment
decision must be made. The risk may be so small that is
not possible to accurately characterize, leading to overre-
action or over-evaluation of the risk, a common problem
in many human health threats [14].
The complexity of rabies PEP decision-making is com-
pounded by the all-or-none nature of the decision, the
potential of treatment to reduce anxiety in the patient,
and fear of litigation should rabies develop following the
withholding of treatment. Furthermore, since either
health insurance companies or state health departments
invariably pay for rabies PEP, the patient's and/or health
care provider's desire to reduce anxiety may not be
aligned with the cost-effectiveness of rabies PEP treat-
ment [6]. Thus, it is not surprising that decisions regard-
ing when to administer PEP continue to challenge public
health departments, emergency rooms, and primary care
physicians.
From the estimates provided by the expert panel, it is
possible to characterize the risk of zoonotic rabies trans-
mission to humans following some non-bite exposures, as
often being "negligible." For example, using the risk esti-
mate of 1 in 1,000,000 following a lick from a cat or dog,
and assuming there are 30,000 people who have this type
of potential exposure each year in the United States, there
would be only three cases of transmission per 100 years
without ever giving rabies PEP in such instances. Con-
versely, the cost of administering rabies PEP to all persons
with this type of exposure would be enormous. In New
York State, from 1995-2000, nearly 30% of all rabies PEP
treatment was given following "indirect" exposure [6].
Assuming that the assessments of risk in our study are
reasonably correct, this statistic illustrates that there is
significant potential to reduce the number of unnecessary
rabies PEP given each year in the United States.
Our study is limited by the fact that the resultant esti-
mates of risk are based solely on the opinions of experts.
While these health professionals have extensive experi-
ence in assessing the potential risk of rabies transmission
and the subsequent need for rabies PEP, purely objective
data is currently unavailable. Thus, there remains a signif-
icant amount of uncertainty as seen in the relatively wide
ranges of risk estimates provided by the panel. It is duly
noted that the Delphi analysis method is inherently
biased due to the composition and opinions of the partic-
ipants. In order to reduce these biases, we included a
large number of participants from various backgrounds
who still had the relevant experience. In addition, all
responses and discussion were managed anonymously so
as to reduce individual predominance.
Since rabies prevalence and prevention practices vary
greatly from state to state, our panel attempted to bridge
this gap by including representatives from many different
regions of the United States. While this may be useful in
achieving a consensus estimate of risk, actual recommen-
dations for rabies PEP should also take into account local
animal species, surroundings, and prevalence rates.
Conclusions
Estimating the risk of human rabies is a challenge for
public health officials as the cost of rabies PEP is high and
controlled studies in humans are neither feasible nor eth-
ical. Our study provides important findings which have
been incorporated into the Advisory Committee on
Immunization Practices recommendations on the risk of
rabies transmission to humans. The results may also pro-
vide guidance for more judicious use of rabies PEP in
common potential exposure situations, including during
a human rabies vaccine shortage [8]. Finally, these results
provide information for human rabies prevention policy
in the form of risk estimates for mathematical models of
the cost-effectiveness of rabies PEP administration [15].
In an era of ever-increasing health care costs, innovative
approaches are needed to identify scientifically valid and
ethical methods of estimating the risk of human rabies
transmission so that unnecessary vaccination can be
avoided when it is not indicated.
Appendix 1
Risk of Human Rabies Delphi Questionnaire
Approximate # of times you have made a professional rec-
ommendation regarding rabies PEP:
Approximate # of years of experience making profes-
sional recommendations regarding rabies PEP:Vaidya et al. BMC Public Health 2010, 10:278
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Assumptions
• Estimated Human Rabies Mortality Rate from a Rabid
Dog or Cat Without PEP [see Additional file 1]
• If the animal is caught but test results are not available
within 48 h, the risk of human rabies and PEP administra-
tion will be considered equivalent to animal not available.
Please answer the questions below to the best of
your ability.
1. An 11-year-old girl living in a state where rabies is
enzootic in skunks is bitten by a skunk while play-
ing in her backyard. She sustained a superficial lacera-
tion on her hand. The wound is not washed or
cleaned. The animal cannot be found. Approximately
2 5 %  o f  s k u n k s  i n  t h e  a r e a  h a v e  t e s t e d  p o s i t i v e  f o r
rabies. The chance that the child will get rabies with-
out rabies post-exposure prophylaxis is:
Please indicate your choice with an X:
A. 1 in 2 D. 1 in 20
B. 1 in 5 E. 1 in 100
C. 1 in 10 F. 1 in 1,000 or less
Do you recommend rabies post-exposure prophylaxis
for this person?(Y/N)
Comments:
2. A mother living in a state where rabies is enzootic
in bats states that she left her 9-month-old daughter
sleeping in the next room. The child started crying
and when the mother returned, she found a bat on
the windowsill. The animal flew out the window and
could not be found. Physical examination of the child
showed no obvious bites or skin abrasions. Approx-
imately 15% of bats in the area have tested positive for
rabies. The chance that the infant will get rabies with-
out rabies post-exposure prophylaxis is:
Please indicate your choice with an X:
A. 1 in 10 D. 1 in 10,000
B. 1 in 100 E. 1 in 100,000
C. 1 in 1,000 F. 1 in 1,000,000 or less
Do you recommend rabies post-exposure prophylaxis
for this person?(Y/N)
Comments:
3. A 65-year-old woman living in a state where rabies
is enzootic in terrestrial animals is  bitten  by an
unprovoked stray dog while walking in the park. She
sustained a superficial laceration on her hand. The
wound is not washed or cleaned. The animal cannot
be found. Approximately 0.1% of dogs in the area have
tested positive for rabies. The chance that the woman
will get rabies without rabies post-exposure prophy-
laxis is:
Please indicate your choice with an X:
A. 1 in 10 D. 1 in 10,000
B. 1 in 100 E. 1 in 100,000
C. 1 in 1,000 F. 1 in 1,000,000 or less
Do you recommend rabies post-exposure prophylaxis
for this person?(Y/N)
Comments:
4. Same scenario as (3), except that the woman is only
licked on the hand by the dog. The affected (licked)
area has evidence of recent superficial scratches and
is not washed or cleaned. The chance that the woman
will get rabies without rabies post-exposure prophy-
laxis is:
Please indicate your choice with an X:
A. 1 in 10 D. 1 in 10,000
B. 1 in 100 E. 1 in 100,000
C. 1 in 1,000 F. 1 in 1,000,000 or less
5. A 15-year-old boy living in a state where rabies is
enzootic in raccoons is bitten by an unprovoked
stray  cat  while walking in a park. He sustained a
superficial laceration on his hand. The wound is not
washed or cleaned. The animal cannot be found.
Approximately 1% of cats in the area have tested posi-
tive for rabies. The chance that the teenager will get
rabies without rabies post-exposure prophylaxis is:
Please indicate your choice with an X:
A. 1 in 10 D. 1 in 10,000
B. 1 in 100 E. 1 in 100,000
C. 1 in 1,000 F. 1 in 1,000,000 or less
6. Same scenario as (5), except that the teenager is
only  licked  on the hand by the cat. The affected
(licked) area has evidence of recent superficial
scratches and is not washed or cleaned. The chance
that the teenager will get rabies without rabies post-
exposure prophylaxis is:
Please indicate your choice with an X:
A. 1 in 10 D. 1 in 10,000
B. 1 in 100 E. 1 in 100,000
C. 1 in 1,000 F. 1 in 1,000,000 or less
7. A patient with unexplained encephalitis dies after a
10-day hospitalization. Rabies is diagnosed postmor-
tem. You are asked by the nurse, who had close con-
tact with the patient, if she needs rabies post-
exposure prophylaxis. She did not wear gloves or a
mask when caring for the patient. She denies having
been bitten or scratched by the patient. The chance
that the nurse will get rabies without rabies post-
exposure prophylaxis is:
Please indicate your choice with an X:
A. 1 in 10 D. 1 in 10,000
B. 1 in 100 E. 1 in 100,000
C. 1 in 1,000 F. 1 in 1,000,000 or less
Additional material
Additional file 1 Table for Estimated Human Rabies Mortality Rate 
from a Rabid Dog or Cat Without PEP. This was the information provided 
to Delphi participants adapted from Babes, B. (1912) Traite de la Rage. J.V. 
Bailliere, Paris, pp 81-119.Vaidya et al. BMC Public Health 2010, 10:278
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